ArticleBritish journal of cancer2024

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.

Hélène Vanacker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.